COVID-19 vaccine 79.3 per cent effective in final tests, claims China s Sinopharm
State-owned Sinopharm is one of at least four Chinese developers that are part of a global race to create vaccines for the disease that has killed 1.8 million people.
Share Via Email
| A+A A-
In this photo provided by Turkish Health Ministry, officials unload the first batch of COVID-19 vaccine, CoronaVac. (Photo | AP) By Associated Press
BEIJING: A Chinese drugmaker said Wednesday its coronavirus vaccine was found to be 79.3 per cent effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.
BEIJING (AP) A Chinese drugmaker said Wednesday its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.
The announcement by a unit of state-owned Sinopharm gave the first official data from a Chinese vaccine s late-stage trial. Its reported effectiveness rate is behind Pfizer Inc. s vaccine at 95% and Moderna Inc. s at 94%. Scientists have cautioned coronavirus vaccines may only be about as effective as flu vaccines, which generally are 50% effective.
Sinopharm is one of at least five Chinese developers that are in a global race to create vaccines for the disease that has killed more than 1.7 million people. More than 1 million health care workers and others in China have received vaccines being developed by Sinopharm and another supplier, Sinovac, under emergency approval while testing was underway.
Chinese drugmaker: Vaccine 79.3% effective in final tests
by The Associated Press
Last Updated Dec 30, 2020 at 1:44 am EDT
BEIJING A Chinese drugmaker said Wednesday its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfil its pledge to supply other developing countries.
State-owned Sinopharm is one of at least four Chinese developers that are part of a global race to create vaccines for the disease that has killed 1.8 million people. More than 1 million health care workers and others in China have received Chinese-developed vaccines under emergency approval while testing was under way.
2020/12/30 14:35 BEIJING (AP) A Chinese drugmaker said Wednesday its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries. State-owned Sinopharm is one of at least four Chinese developers that are part of a global race to create vaccines for the disease that has killed 1.8 million people. More than 1 million health care workers and others in China have received Chinese-developed vaccines under emergency approval while testing was under way. Sinopharm, or China National Pharmaceutical Group, has applied for approval of its vaccine following the third and final stage of testing, a unit of the company, Beijing Biological Products Institute Ltd., said on its website.